drugset
drugset / Trial / NCT00435292

Study of Flavocoxid (Limbrel) vs Naproxen in Subjects With Mod-Severe Osteoarthritis of the Knee

NCT00435292 ↗

Completed 350 enrolled Primus Pharmaceuticals
RandomizedParallel-groupTriple-blindTreatment

Summary

Randomized, double-blind, placebo controlled parallel group, multi center study in subjects with moderate-severe osteoarthritis.

Timeline

Start
2006-04
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Naproxen Small molecule 500 mg —

Indications

osteoarthritis